AI Summary
This article discusses the synthesis and evaluation of 18F-labeled phenylpiperazine-like dopamine D3 receptor radioligands for use in positron emission tomography (PET) imaging. The research focuses on developing radioligands that can accurately target and visualize dopamine D3 receptors in the brain. This has implications for studying neurological disorders and drug development. The study evaluates the efficacy and specificity of these radioligands for PET imaging purposes.